What is the price target for IGC stock?
6 analysts have analysed IGC and the average price target is 4.08 USD. This implies a price increase of 1170.63% is expected in the next year compared to the current price of 0.3211.
IGC PHARMA INC (IGC) Forecast, Price Target & Analyst Ratings
NYSEARCA:IGC • US45408X3089
Current stock price
0.3211 USD
-0.02 (-4.77%)
Last:
Analyst forecast overview
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for IGC PHARMA INC (IGC).
Forecast Snapshot
Next Earnings Forecast
Earnings Estimate- Release Date
- Jun 25, 2026
- Period
- Q3 / 2026
- EPS Estimate
- -$0.02
- Revenue Estimate
- 261.59K
Price Target Details & History
Consensus Price Target and Range
Mean target
$4.08
Upside
+ 1,170.63%
From current price of $0.32 to mean target of $4.08, Based on 6 analyst forecasts
Low
$3.03
Median
$4.08
High
$5.25
Price Target Revisions
1 Month
10.34%
3 Months
10.34%
Price Target Summary
6 Wall Street analysts provided a forecast for the next 12 months for IGC. The average price target is 4.08 USD. This implies a price increase of 1170.63% is expected in the next year compared to the current price of 0.3211.
The average price target has been revised upward by 10.34% in the past 3 months.
Analyst Ratings & History
Current Analyst Ratings
Analyst Ratings History
Analyst Ratings Consensus
ChartMill Buy Consensus
80.00%
IGC was analyzed by 6 analysts. The buy percentage consensus is at 80. So analysts seem to be have mildly positive about IGC.
In the previous month the buy percentage consensus was at a similar level.
IGC was analyzed by 6 analysts. More opinions would make the average more meaningful.
Recent Upgrades & Downgrades
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2026-04-08 | Ascendiant Capital | Maintains | Buy -> Buy |
| 2026-02-23 | Ascendiant Capital | Maintains | Buy -> Buy |
| 2025-12-09 | Ascendiant Capital | Maintains | Buy -> Buy |
| 2025-08-26 | Ascendiant Capital | Maintains | Buy -> Buy |
| 2025-03-06 | Alliance Global Partners | Reiterate | Buy -> Buy |
| 2025-02-24 | Ascendiant Capital | Maintains | Buy -> Buy |
| 2024-12-05 | Ascendiant Capital | Maintains | Buy -> Buy |
| 2024-09-03 | Ascendiant Capital | Maintains | Buy -> Buy |
| 2024-07-29 | Ascendiant Capital | Maintains | Buy -> Buy |
| 2024-07-17 | Alliance Global Partners | Initiate | Buy |
| 2024-06-21 | Ascendiant Capital | Reiterate | Buy -> Buy |
Next Earnings Forecast Details
Next Earnings Details
- Release Date
- Jun 25, 2026
- Period
- Q3 / 2026
- EPS Estimate
- -$0.02
- Revenue Estimate
- 261.59K
- Revenue Q2Q
- 1.79%
- EPS Q2Q
- 11.75%
- Number of Analysts
- 3
Next Earnings Revisions
Revenue (1 Month)
0.00%
Revenue (3 Months)
-20.31%
EPS (1 Month)
0.00%
EPS (3 Months)
-30.41%
Next Earnings Summary
IGC is expected to report earnings on 6/25/2026. The consensus EPS estimate for the next earnings is -0.02 USD and the consensus revenue estimate is 261.59K USD.
The next earnings revenue estimate has been revised downward by 20.31% in the past 3 months. Downward revisions are a negative sign and indicate that analysts are more pessimistic about the next earnings compared to 3 months ago.
Full Analyst Estimates 2026 - 2027
Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates
| 2023 | 2024 | 2025 | 2026 | 2027 | ||
|---|---|---|---|---|---|---|
| Revenue YoY % growth | 910K 127.50% | 1.345M 47.80% | 1.271M -5.50% | 1.118M -12.04% | 1.264M 13.06% | |
| EBITDA YoY % growth | -10.53M -4.99% | -8.161M 22.50% | -6.611M 18.99% | N/A | N/A | |
| EBIT YoY % growth | -11.19M -4.78% | -8.798M 21.38% | -7.229M 17.83% | -7.976M -10.33% | -9.373M -17.51% | |
| Operating Margin | -1,229.67% | -654.13% | -568.76% | -713.41% | -741.52% | |
| EPS YoY % growth | N/A | N/A | -0.08 62.20% | -0.08 7.95% | -0.08 -1.45% |
All data in USD
Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates
| Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | |
|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.02 11.75% | -0.02 -111.80% | -0.02 12.84% | -0.02 4.32% | -0.02 0.38% | -0.02 |
| Revenue Q2Q % growth | 261.59K 1.79% | 264.115K -19.97% | 248.46K -24.25% | 250.48K 31.14% | 253.51K -3.09% | 259.57K -1.72% |
| EBITDA Q2Q % growth | N/A | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -1.96M 32.44% | -1.958M 33.05% | -2.073M -8.97% | -2.072M 28.59% | -2.071M -5.64% | -2.066M -5.52% |
All data in USD
Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data
Long Term Forward Growth Forecast Summary
Long Term EPS Growth (CAGR)
EPS Next 3 Year
N/A
EPS Next 5 Year
N/A
Long Term Revenue Growth (CAGR)
Revenue Next 3 Year
N/A
Revenue Next 5 Year
N/A
Long Term EBIT Growth (CAGR)
EBIT Next 3 Year
N/A
EBIT Next 5 Year
N/A
IGC PHARMA INC / IGC Forecast FAQ
When does IGC PHARMA INC (IGC) report earnings?
IGC PHARMA INC (IGC) will report earnings on 2026-06-25.
What are the consensus estimates for IGC stock next earnings?
The consensus EPS estimate for the next earnings of IGC PHARMA INC (IGC) is -0.02 USD and the consensus revenue estimate is 261.59K USD.
How many analysts have analysed IGC PHARMA INC (IGC)?
The number of analysts covering IGC PHARMA INC (IGC) is 6.